17-03, MEDIVIR: ULI HACKSELL KÖPT AKTIER FÖR CA 0,5 MLN KR. 26-02, BÖRSEN: NEDSTÄLL VÄNTAS SEDAN RÄNTEORO UTLÖST
Fredrik Lehmann, Erika A Currier, Roger Olsson, Uli Hacksell, Kristina Luthman Bioorganic & medicinal chemistry - 2005-01-01 A biocatalytic route to P-chirogenic compounds by lipase-catalyzed desymmetrization of a prochiral
Forskningsbolaget Medivirs vd Uli Hacksell har den 18-19 februari köpt Aktieanalys Medivir Investerare har över tid godtagit stadigt lägre I. 2021-03-16, Uli Hacksell, Styrelseledamot, Eget, Förvärv, MVIR AB B, 52000, Antal, 8,78 SEK 2020-02-19, Uli Hacksell, VD, Eget, Förvärv, Medivir AB ser. STOCKHOLM (Nyhetsbyrån Direkt) Uli Hacksell, tidigare vd för och numera styrelseledamot i Medivir, har köpt 52.000 aktier i Medivir för 8:78 Proff.se ger dig information om befattningar om Uli Alf Hacksell. Se hans officiella befattningar (5) och relationer (40) i näringslivet - och vilka branscher Uli Alf Forskningsbolaget Medivirs vd Uli Hacksell har den 18-19 februari köpt Aktieanalys Medivir Investerare har över tid godtagit stadigt lägre I. Media bank. Images. Medivir logo. Management team.
Education: PhD at Uppsala University. Background: Senior positions in major pharmaceutical 14 Aug 2017 Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017. John Kaiser, Chief Business Uli Hacksell. Board Member.
Dr Uli Hacksell (1950) has over 20 years of international management experience from both large pharmaceutical and biotech companies. He has served as CEO at two NASDAQ-listed biopharmaceutical companies, Cerecor (2016–2017) and ACADIA Pharmaceuticals (2000–2015), and led ACADIA from a private start-up to becoming a public multibillion dollar company.
Uli Hacksell Forskningsbolaget Medivirs vd Uli Hacksell har den 18-19 februari köpt Aktieanalys Medivir Investerare har över tid godtagit stadigt lägre I 27 828 000 SEK, 3 600 000, 7,73, 27 828 000 SEK. 16 mars 2021, 16 mars 2021, A Achat. Uli Hacksell.
- Uli Hacksell assumed leadership responsibility for Medivir as acting CEO in the fall of 2018 in conjunction with the strengthened focus on clinical cancer projects and a comprehensive restructuring of the company. Uli has invested enormous energy in shaping and developing Medivir into the company it is today.
22 ago 2016 Nuova tragedia tra gli appassionati dello sport estremo, a quattro giorni dalla morte dell'altoatesino Uli Emanuele: il giovane, 31 anni, è finito Management for Directors and Directors of Photography. 11 Mar 2015 On March 11, 2015, Uli Hacksell, Ph.D. notified us of his resignation as our President and Chief Executive Officer and as a member of our 19 Mar 2015 In addition, Acadia's longtime CEO, Uli Hacksell, announced his immediate retirement from the company and resigned from the board.
Magnus Christensen. Yilmaz Mahshid. Board of Directors. Uli Hacksell
Forskningsbolaget Medivirs vd Uli Hacksell har den 18-19 februari köpt Aktieanalys Medivir Investerare har över tid godtagit stadigt lägre I
27 828 000 SEK, 3 600 000, 7,73, 27 828 000 SEK. 16 mars 2021, 16 mars 2021, A Achat. Uli Hacksell. Member of the Board of Directors Administrateur.
Antenna efficiency
En otroligt skicklig affärsman med många års erfarenhet och många kontakter i USA Jag flaggar Michael Shalmi valdes till styrelseordförande och Uli Hacksell till styrelseledamot vid årsstämman den 23 maj 2019. En utvärdering av företagets kliniska och Farmaciprofilen Uli Hacksell kliver fram när bioteknikföretaget Medivir ska fokusera mer på klinisk utveckling och byter vd med omedelbar 17-03, MEDIVIR: ULI HACKSELL KÖPT AKTIER FÖR CA 0,5 MLN KR. 26-02, BÖRSEN: NEDSTÄLL VÄNTAS SEDAN RÄNTEORO UTLÖST DI - 2020-10-20 11:42:58.
Han går även igenom
Medivir: CEO Uli Hacksell presents at Growth Day 2020. Medivir. Redeye Event.
Kontrollera reg skylt
Uli Hacksell (R)-11-Hydroxyaporphine (2) and (R)-11-hydroxy-10-methylaporphine (3) were synthesized from natural morphine by using new, short, and efficient synthetic sequences. The dopaminergic
Dr. Hacksell served as Chief Executive Uli Hacksell. Born: 1950 Title: Member of the Board since 2018. Education: PhD at Uppsala University. Background: Senior positions in major pharmaceutical 14 Aug 2017 Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017.
Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies. As the CEO of ACADIA Pharmaceuticals from 2000−2015, he led its View Uli Hacksell’s profile on LinkedIn, the world's largest professional community. Uli has 1 job listed on their profile. See the complete profile on LinkedIn and discover Uli’s connections Uli Hacksell. Born: 1950 Title: Member of the Board since 2018. Education: PhD at Uppsala University.
Styrelseledamot sedan 2015. Läs mer. Prof. Uli Hacksell.